EU Launches Antitrust Investigation into Sanofi Over Alleged Disparagement of Competitor's Flu Vaccine
The European Commission has initiated a formal antitrust investigation against Sanofi (SNY) to determine if the company violated EU competition rules by running a campaign that allegedly disparaged its only rival flu vaccine for vulnerable patients. The probe could impact Sanofi’s market position and regulatory standing in Europe.
Tickers: $SNY
Topics: competition_laws pharmaceuticals vaccines